BioMarin Pharmaceuticals Inc BMRN
$57.23
+0.93%
at last close
Analyst Consensus
- Consensus Rating
- Buy (18 Buy · 5 Hold · 0 Sell)
- Average Price Target
- $88.39
- Implied Upside
- +54.4%
- Price Target Range
- $60.00 – $120.00
- Analysts (12 mo)
- 23
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-04 | JP MorganJessica Fye |
Maintains | Overweight | $87 → $86 |
| 2026-11-03 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $122 → $119 |
| 2026-11-03 | OppenheimerLeland Gershell |
Maintains | Outperform | $97 → $94 |
| 2026-11-03 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | $60 |
| 2026-11-03 | RBC CapitalLuca Issi |
Maintains | Sector perform | $62 → $60 |
| 2026-11-03 | StifelPaul Matteis |
Maintains | Hold | $70 → $66 |
| 2026-10-21 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $124 → $122 |
| 2026-10-20 | JP MorganJessica Fye |
Maintains | Overweight | $86 → $87 |
| 2026-10-20 | Cantor FitzgeraldOlivia Brayer Saunders |
Reiterates | Overweight | $86 |
| 2026-10-15 | UBSJoon Lee |
Assumes | Buy | $114 → $88 |
| 2026-10-14 | BarclaysEliana Merle |
Maintains | Overweight | $111 → $114 |
| 2026-09-10 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | $60 |
| 2026-09-01 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $88 → $90 |
| 2026-08-31 | JefferiesAkash Tewari |
Maintains | Buy | $104 → $105 |
| 2026-08-31 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $59 → $60 |
| 2026-08-19 | BMO CapitalDavid Lebowitz |
Initiates coverage on | Outperform | $98 |
| 2026-08-18 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $60 → $59 |
| 2026-08-17 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $82 → $88 |
| 2026-08-17 | BarclaysEliana Merle |
Maintains | Overweight | $105 → $111 |
| 2026-08-10 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $111 → $114 |
| 2026-08-07 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $119 → $124 |
| 2026-08-07 | OppenheimerLeland Gershell |
Maintains | Outperform | $95 → $97 |
| 2026-08-07 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $50 → $60 |
| 2026-07-16 | CitigroupEric Joseph |
Maintains | Buy | $75 → $76 |
| 2026-07-07 | RBC CapitalLuca Issi |
Maintains | Sector perform | $66 → $62 |
| 2026-05-22 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $116 → $111 |
| 2026-05-19 | B of A SecuritiesJason Zemansky |
Maintains | Buy | $85 → $80 |
| 2026-05-19 | CitigroupEric Joseph |
Initiates coverage on | Buy | $75 |
| 2026-05-18 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $55 → $50 |
| 2026-05-11 | Goldman SachsSalveen Richter |
Reinstates | Buy → Neutral | $69 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $57.23
- Market Cap
- $11.09 billion
- 52-Week Range
- $49.26 – $70.98
- Average Volume
- 2.51 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.